• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Expansion

Sofinnova et al. inject €36m into Avantium

  • Ellie Pullen
  • 05 June 2014
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Netherlands-based Avantium, a specialist in bio-sourced plastics, has secured €36m in funding from a consortium of venture capital firms and trade players including Sofinnova Partners and Coca-Cola.

Trade players Swire Pacific, The Coca-Cola Company, Danone and Alpla have been accompanied in the round by a syndicate of existing venture capital backers, comprising Sofinnova, Capricorn Venture Partners, Aescap Venture, Navitas Capital, Aster Capital and De Hoge Dennen Capital, as well as ING Corporate Investments.

The fresh funding will allow Avantium to further advance towards commercialisation of its PEF product, which is a 100% bio-based plastic. The company is also working towards the launch of its first commercial scale plant, which it hopes will be operational by 2017.

Avantium

  • DEAL:

    Expansion

  • VALUE:

    €36m

  • LOCATION:

    Amsterdam

  • SECTOR:

    Speciality chemicals

  • FOUNDED:

    2000

Previous funding
Avantium received €31m funding in February 2002 from a group of investors including DFJ Esprit and MVM Life Sciences Partners. According to unquote" data, €11m of the funding came from the conversion of an existing convertible note issued by an investor consortium in 2001. Existing shareholders also provided €8m in equity to the round.

Aescap then led an €18m round in October 2008 with participation from Capricorn, Navitas and ING.

In June 2011, Sofinnova, Aster, De Hoge Dennen and existing investors Aescap, Capricorn, Navitas and ING injected €25m into the company alongside a €5m subsidy and innovation credit from the Dutch Ministry of Economy, according to unquote" data. Some of the capital was used to buy out the stakes held by DFJ Esprit and AlpInvest, among others.

Company
Founded in 2000 and headquartered in Amsterdam, Avantium develops technology designed to convert plant-based materials into bio-based chemicals and bioplastics.

Its PEF product is a bio-based polyester designed to allow for lighter, thinner and stronger bottles, as well as extending shelf-life.

People
Tom van Aken is the CEO of Avantium. Sofinnova managing partner Denis Lucquin, Aescap partner Michiel de Haan and Capricorn partner Claude Stoufs sit on the company's supervisory board.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Expansion
  • Benelux
  • Industrials
  • Netherlands
  • Sofinnova Partners
  • De Hoge Dennen Capital
  • ING
  • DFJ Esprit

More on Expansion

Wealth managers and financial advisers
Blackstone takes minority stake in Groupe Premium

Deal values French wealth manager at EUR 1.15bn after earlier full exit attempt saw Eurazeo target EUR 1.5bn

  • Expansion
  • 31 July 2023
Risk and compliance management services
e-Attestations aims to triple size with new Keensight backing

Keensight is investing in the risk management platform via its EUR 1bn fifth fund, which closed in 2019

  • Expansion
  • 25 July 2023
Bolt-ons and buy-and-build platforms
The Bolt-Ons Digest - 3 July 2023

Unquote’s selection of the latest add-ons with Palatine's Anthesis, Nordic Capital's Regnology, Waterland's Janssen and more

  • Expansion
  • 03 July 2023
Valentina Vitali of Limerston Capital
GP Profile: Limerston Capital anticipates higher volume but more complex M&A as market steadies

UK-based GP is seeing dealflow driven by carve-outs and buy-and-build in a market where organic multiple arbitrage is no longer a given

  • GPs
  • 07 June 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013